EUVIMEDOpdag EUVIMED
Crossref

Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling

M Martin-Flores iD, A M Lorenzutti iD, L Pelligand iD

Journal of Small Animal Practice · 2026-11 · 67 (11) · 1071-1074

DOI: 10.1111/jsap.70144 ↗

At a glance

Journal article in Journal of Small Animal Practice, published online on 2026-05-24. Written by M Martin-Flores and 2 co-authors. Institution: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA. Major MEDLINE topics: Metoclopramide, Antiemetics, Dog Diseases, Vomiting. 15 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metoclopramide is used for prevention or treatment of emesis and gastroesophageal reflux in dogs. Historically, it has been administered three to four times a day. However, reports of adverse reactions associated with intravenous boluses raise concerns. A more modern trend is to administer the total daily dose as a constant rate infusion of 1 to 2 mg/kg/day. A loading dose prior to the infusion is often omitted, which can delay the onset of action. Adequate loading doses for these constant rate infusions are not known. We have reanalysed pharmacokinetic data from dogs receiving metoclopramide and modelled its behaviour when administered as a constant rate infusion, with and without loading doses. We have quantified the delay expected if loading doses are not administered and calculated appropriate loading doses designed to reach the target concentration while omitting unnecessarily high plasma levels. If a loading dose is omitted, a delay of 3.25 hours for reaching a steady state can be expected. Loading doses of 0.05 and 0.1 mg/kg are recommended for infusions of 1 and 2 mg/kg/day, respectively, in order to reach targeted plasma levels almost immediately.

Subjects

MeSH terms (MEDLINE)

MetoclopramideAntiemeticsDog DiseasesVomitingAnimalsDogsInfusions, IntravenousGastroesophageal RefluxDose-Response Relationship, DrugInjections, Intravenous

Substances

MetoclopramideAntiemetics

Authors and institutions

  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Facultad de Ciencias Agropecuarias, IRNASUS CONICET - Universidad Católica de Córdoba, Córdoba, Argentina.
  • Comparative Biomedical Sciences, The Royal Veterinary College, London, UK.
  • Clinical Services and Sciences, The Royal Veterinary College, London, UK.

ORCID profiles: M Martin-Flores, A M Lorenzutti, L Pelligand

Cite

APA

Martin-Flores, M., Lorenzutti, A. M., & Pelligand, L. (2026). Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling. Journal of Small Animal Practice, 67(11), 1071-1074. https://doi.org/10.1111/jsap.70144

Vancouver

Martin-Flores M, Lorenzutti AM, Pelligand L. Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling. Journal of Small Animal Practice. 2026;67(11):1071-1074. doi:10.1111/jsap.70144

BibTeX
@article{MartinFlores2026,
  author = {Martin-Flores, M and Lorenzutti, A M and Pelligand, L},
  title = {Bolus and infusions of metoclopramide: insights on benefits and risks from pharmacokinetic modelling},
  journal = {Journal of Small Animal Practice},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {1071--1074},
  doi = {10.1111/jsap.70144}
}
Start for free →